These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 25420029)

  • 1. Laser photocoagulation for proliferative diabetic retinopathy.
    Evans JR; Michelessi M; Virgili G
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011234. PubMed ID: 25420029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
    Martinez-Zapata MJ; Martí-Carvajal AJ; Solà I; Pijoán JI; Buil-Calvo JA; Cordero JA; Evans JR
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008721. PubMed ID: 25418485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-vascular endothelial growth factor for diabetic macular oedema.
    Virgili G; Parravano M; Menchini F; Evans JR
    Cochrane Database Syst Rev; 2014 Oct; (10):CD007419. PubMed ID: 25342124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
    Smith JM; Steel DH
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy laser photocoagulation for diabetic macular oedema.
    Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
    Martinez-Zapata MJ; Salvador I; Martí-Carvajal AJ; Pijoan JI; Cordero JA; Ponomarev D; Kernohan A; Solà I; Virgili G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD008721. PubMed ID: 36939655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different lasers and techniques for proliferative diabetic retinopathy.
    Moutray T; Evans JR; Lois N; Armstrong DJ; Peto T; Azuara-Blanco A
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012314. PubMed ID: 29543992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular grid laser photocoagulation for branch retinal vein occlusion.
    Lam FC; Chia SN; Lee RM
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD008732. PubMed ID: 25961835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.
    Virgili G; Michelessi M; Parodi MB; Bacherini D; Evans JR
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006537. PubMed ID: 26493180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.
    Zhu Y; Zhang T; Xu G; Peng L
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011160. PubMed ID: 27977064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser therapy for retinopathy in sickle cell disease.
    Myint KT; Sahoo S; Thein AW; Moe S; Ni H
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010790. PubMed ID: 26451693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for central serous chorioretinopathy: a network meta-analysis.
    Salehi M; Wenick AS; Law HA; Evans JR; Gehlbach P
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011841. PubMed ID: 26691378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aflibercept for neovascular age-related macular degeneration.
    Sarwar S; Clearfield E; Soliman MK; Sadiq MA; Baldwin AJ; Hanout M; Agarwal A; Sepah YJ; Do DV; Nguyen QD
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011346. PubMed ID: 26857947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
    Virgili G; Parravano M; Menchini F; Brunetti M
    Cochrane Database Syst Rev; 2012 Dec; 12():CD007419. PubMed ID: 23235642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.
    Schwartz SG; Flynn HW; Wang X; Kuriyan AE; Abariga SA; Lee WH
    Cochrane Database Syst Rev; 2020 May; 5(5):CD006126. PubMed ID: 32408387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.
    Dervenis P; Dervenis N; Smith JM; Steel DH
    Cochrane Database Syst Rev; 2023 May; 5(5):CD008214. PubMed ID: 37260074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.